Use Additional Code Notes in Chapter 21: Factors influencing health status and contact with health services ICD-10-CM
A Use Additional Code note means a second code should be added, after this one, to fully describe the condition. In Chapter 21 (Z00-Z99), notes printed in the chapter name other codes 42 times, and Use Additional Code Notes anywhere in the Tabular List name the chapter’s codes 304 times, covering 70 distinct codes, categories and ranges. Switch views to read the list either way.
Use Additional Code Notes by the code that carries the note
- Z02.83 Encounter for blood-alcohol and blood-drug test
- code for findings of alcohol or drugs in blood (R78.-)
- Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm
- Z09 Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
- code to identify any family history of malignant neoplasm (Z80.-)
- Z12.72 Encounter for screening for malignant neoplasm of vagina
- code to identify acquired absence of uterus (Z90.71-)
- code, if applicable, for any personal history of malignant neoplasm (Z85.-)
- Z15.2 Genetic susceptibility to obesity
- code to identify body mass index (BMI), if known (Z68.-)
- immunization not carried out because of contraindication (Z28.0-)
- immunization not carried out because of patient decision for other and unspecified reason (Z28.2-)
- immunization not carried out because of patient decision for reasons of belief or group pressure (Z28.1)
- immunization not carried out for other reason (Z28.8-)
- Z40.0 Encounter for prophylactic surgery for risk factors related to malignant neoplasms applies to 5 codes
- code to identify risk factor, such as genetic susceptibility to malignant neoplasm Z15.-
- Z47.1 Aftercare following joint replacement surgery
- code to identify the joint (Z96.6-)
- Z47.81 Encounter for orthopedic aftercare following surgical amputation
- code to identify the limb amputated (Z89.-)
- Z71.3 Dietary counseling and surveillance
- code to identify body mass index (BMI), if known (Z68.-)
- code for alcohol abuse or dependence (F10.-)
- Z71.6 Tobacco abuse counseling
- code for nicotine dependence (F17.-)
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels applies to 3 codes
- code to identify intraocular lens implant status (Z96.1)
- Z11.51 Encounter for screening for human papillomavirus (HPV)
- Z01.41 Encounter for routine gynecological examination: for screening for human papillomavirus, if applicable, (Z11.51)
- Z12.72 Encounter for screening for malignant neoplasm of vagina
- Z01.41 Encounter for routine gynecological examination: for screening vaginal pap smear, if applicable (Z12.72)
- Z15.09 Genetic susceptibility to other malignant neoplasm
- D61.02 Shwachman-Diamond syndrome: code, if applicable, for genetic susceptibility to other malignant neoplasm (Z15.09)
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels: genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
- Z40.0 Encounter for prophylactic surgery for risk factors related to malignant neoplasms: code to identify risk factor, such as genetic susceptibility to malignant neoplasm Z15.-
- Chapter 1 (A00-B99) Certain infectious and parasitic diseases: code to identify resistance to antimicrobial drugs (Z16.-)
- Block J09-J18 Influenza and pneumonia: code, if applicable, to identify resistance to antimicrobial drugs (Z16.-)
- Z17.0 Estrogen receptor positive status [ER+]
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels: estrogen receptor positive status (Z17.0)
- C50 Malignant neoplasm of breast: code to identify estrogen, and other hormones and factors receptor status (Z17.-)
- H44.7 Retained (old) intraocular foreign body, nonmagnetic: code to identify nonmagnetic foreign body (Z18.01-Z18.10, Z18.12, Z18.2-Z18.9)
- T56 Toxic effect of metals: code to identify any retained metal foreign body, if applicable (Z18.0-, T18.1-)
- Z18.11 Retained magnetic metal fragments
- H44.6 Retained (old) intraocular foreign body, magnetic: code to identify magnetic foreign body (Z18.11)
- Z18.12 Retained nonmagnetic metal fragments
- H44.7 Retained (old) intraocular foreign body, nonmagnetic: code to identify nonmagnetic foreign body (Z18.01-Z18.10, Z18.12, Z18.2-Z18.9)
- Z18.2-Z18.9 Retained plastic fragments to Retained foreign body fragments, unspecified material 9 codes
- H44.7 Retained (old) intraocular foreign body, nonmagnetic: code to identify nonmagnetic foreign body (Z18.01-Z18.10, Z18.12, Z18.2-Z18.9)
- H02.81 Retained foreign body in eyelid: code to identify the type of retained foreign body (Z18.-)
- H05.5 Retained (old) foreign body following penetrating wound of orbit: code to identify the type of retained foreign body (Z18.-)
- L92.3 Foreign body granuloma of the skin and subcutaneous tissue: code to identify the type of retained foreign body (Z18.-)
- M60.2 Foreign body granuloma of soft tissue, not elsewhere classified: code to identify the type of retained foreign body (Z18.-)
- R78 Findings of drugs and other substances, not normally found in blood: code to identify any retained foreign body, if applicable (Z18.-)
- R79 Other abnormal findings of blood chemistry: code to identify any retained foreign body, if applicable (Z18.-)
- R82 Other and unspecified abnormal findings in urine: code to identify any retained foreign body, if applicable (Z18.-)
- Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes: code to identify any retained foreign body, if applicable (Z18.-)
- Block T51-T65 Toxic effects of substances chiefly nonmedicinal as to source: to identify any retained foreign body, if applicable (Z18.-)
- C61 Malignant neoplasm of prostate: hormone sensitivity status (Z19.1-Z19.2)
- Z20.822 Contact with and (suspected) exposure to COVID-19
- M35.81 Multisystem inflammatory syndrome: exposure to COVID-19 or SARS-CoV-2 infection (Z20.822)
- Z21 Asymptomatic human immunodeficiency virus [HIV] infection status
- O99.83 Other infection carrier state complicating pregnancy, childbirth and the puerperium: code to identify the carrier state (Z22.-)
- Z28.3 Underimmunization status: immunization not carried out because of contraindication (Z28.0-)
- Z28.1 Immunization not carried out because of patient decision for reasons of belief or group pressure
- Z28.3 Underimmunization status: immunization not carried out because of patient decision for reasons of belief or group pressure (Z28.1)
- Z28.2- Immunization not carried out because of patient decision for other and unspecified reason 3 codes
- Z28.3 Underimmunization status: immunization not carried out because of patient decision for other and unspecified reason (Z28.2-)
- Z28.3 Underimmunization status: immunization not carried out for other reason (Z28.8-)
- Z37.0 Single live birth
- Chapter 15 (O00-O9A) Pregnancy, childbirth and the puerperium: code, if applicable, from category Z3A, Weeks of gestation, to identify the specific week of the pregnancy, if known.
- Z57.31 Occupational exposure to environmental tobacco smoke
- C07 Malignant neoplasm of parotid gland: occupational exposure to environmental tobacco smoke (Z57.31)
- C08 Malignant neoplasm of other and unspecified major salivary glands: occupational exposure to environmental tobacco smoke (Z57.31)
- C09 Malignant neoplasm of tonsil: occupational exposure to environmental tobacco smoke (Z57.31)
- C10 Malignant neoplasm of oropharynx: occupational exposure to environmental tobacco smoke (Z57.31)
- C11 Malignant neoplasm of nasopharynx: occupational exposure to environmental tobacco smoke (Z57.31)
- C12 Malignant neoplasm of pyriform sinus: occupational exposure to environmental tobacco smoke (Z57.31)
- C13 Malignant neoplasm of hypopharynx: occupational exposure to environmental tobacco smoke (Z57.31)
- C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx: occupational exposure to environmental tobacco smoke (Z57.31)
- C32 Malignant neoplasm of larynx: occupational exposure to environmental tobacco smoke (Z57.31)
- C33 Malignant neoplasm of trachea: occupational exposure to environmental tobacco smoke (Z57.31)
- C34 Malignant neoplasm of bronchus and lung: occupational exposure to environmental tobacco smoke (Z57.31)
- C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs: occupational exposure to environmental tobacco smoke (Z57.31)
- D00.0 Carcinoma in situ of lip, oral cavity and pharynx: occupational exposure to environmental tobacco smoke (Z57.31)
- D02 Carcinoma in situ of middle ear and respiratory system: occupational exposure to environmental tobacco smoke (Z57.31)
- G31.84 Mild cognitive impairment of uncertain or unknown etiology: occupational exposure to environmental tobacco smoke (Z57.31)
- H65 Nonsuppurative otitis media: occupational exposure to environmental tobacco smoke (Z57.31)
- H66 Suppurative and unspecified otitis media: occupational exposure to environmental tobacco smoke (Z57.31)
- Block I10-I1A Hypertensive diseases: occupational exposure to environmental tobacco smoke (Z57.31)
- I20 Angina pectoris: occupational exposure to environmental tobacco smoke (Z57.31)
- I21 Acute myocardial infarction: occupational exposure to environmental tobacco smoke (Z57.31)
- I22 Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction: occupational exposure to environmental tobacco smoke (Z57.31)
- I25 Chronic ischemic heart disease: occupational exposure to environmental tobacco smoke (Z57.31)
- Block I60-I69 Cerebrovascular diseases: occupational exposure to environmental tobacco smoke (Z57.31)
- I70 Atherosclerosis: occupational exposure to environmental tobacco smoke (Z57.31)
- Chapter 10 (J00-J99) Diseases of the respiratory system: occupational exposure to environmental tobacco smoke (Z57.31)
- J37 Chronic laryngitis and laryngotracheitis: occupational exposure to environmental tobacco smoke (Z57.31)
- J40 Bronchitis, not specified as acute or chronic: occupational exposure to environmental tobacco smoke (Z57.31)
- J41 Simple and mucopurulent chronic bronchitis: occupational exposure to environmental tobacco smoke (Z57.31)
- J42 Unspecified chronic bronchitis: occupational exposure to environmental tobacco smoke (Z57.31)
- J45 Asthma: occupational exposure to environmental tobacco smoke (Z57.31)
- J47 Bronchiectasis: occupational exposure to environmental tobacco smoke (Z57.31)
- J81 Pulmonary edema: occupational exposure to environmental tobacco smoke (Z57.31)
- J98 Other respiratory disorders: occupational exposure to environmental tobacco smoke (Z57.31)
- K05 Gingivitis and periodontal diseases: occupational exposure to environmental tobacco smoke (Z57.31)
- K11 Diseases of salivary glands: occupational exposure to environmental tobacco smoke (Z57.31)
- K12 Stomatitis and related lesions: occupational exposure to environmental tobacco smoke (Z57.31)
- K13 Other diseases of lip and oral mucosa: occupational exposure to environmental tobacco smoke (Z57.31)
- K14 Diseases of tongue: occupational exposure to environmental tobacco smoke (Z57.31)
- T65.22 Toxic effect of tobacco cigarettes: code for exposure to second hand tobacco smoke (Z57.31, Z77.22)
- Z85 Personal history of malignant neoplasm: occupational exposure to environmental tobacco smoke (Z57.31)
- Z68.1-Z68.45 Body mass index [BMI] 19.9 or less, adult to Body mass index [BMI] 70 or greater, adult 27 codes
- E66 Overweight and obesity: code to identify body mass index (BMI), if known, for adults (Z68.1-Z68.45) or pediatrics (Z68.5-)
- E66 Overweight and obesity: code to identify body mass index (BMI), if known, for adults (Z68.1-Z68.45) or pediatrics (Z68.5-)
- E88.82 Obesity due to disruption of MC4R pathway: code to identify body mass index (BMI), if known (Z68.-)
- R63.6 Underweight: code to identify body mass index (BMI), if known (Z68.-)
- Z15.2 Genetic susceptibility to obesity: code to identify body mass index (BMI), if known (Z68.-)
- Z71.3 Dietary counseling and surveillance: code to identify body mass index (BMI), if known (Z68.-)
- Z72.0 Tobacco use
- C00 Malignant neoplasm of lip: tobacco use (Z72.0)
- C01 Malignant neoplasm of base of tongue: tobacco use (Z72.0)
- C02 Malignant neoplasm of other and unspecified parts of tongue: tobacco use (Z72.0)
- C03 Malignant neoplasm of gum: tobacco use (Z72.0)
- C04 Malignant neoplasm of floor of mouth: tobacco use (Z72.0)
- C05 Malignant neoplasm of palate: tobacco use (Z72.0)
- C06 Malignant neoplasm of other and unspecified parts of mouth: tobacco use (Z72.0)
- C07 Malignant neoplasm of parotid gland: tobacco use (Z72.0)
- C08 Malignant neoplasm of other and unspecified major salivary glands: tobacco use (Z72.0)
- C09 Malignant neoplasm of tonsil: tobacco use (Z72.0)
- C10 Malignant neoplasm of oropharynx: tobacco use (Z72.0)
- C11 Malignant neoplasm of nasopharynx: tobacco use (Z72.0)
- C12 Malignant neoplasm of pyriform sinus: tobacco use (Z72.0)
- C13 Malignant neoplasm of hypopharynx: tobacco use (Z72.0)
- C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx: tobacco use (Z72.0)
- C32 Malignant neoplasm of larynx: tobacco use (Z72.0)
- C33 Malignant neoplasm of trachea: tobacco use (Z72.0)
- C34 Malignant neoplasm of bronchus and lung: tobacco use (Z72.0)
- C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs: tobacco use (Z72.0)
- D00.0 Carcinoma in situ of lip, oral cavity and pharynx: tobacco use (Z72.0)
- D02 Carcinoma in situ of middle ear and respiratory system: tobacco use (Z72.0)
- G31.84 Mild cognitive impairment of uncertain or unknown etiology: tobacco use (Z72.0)
- H65 Nonsuppurative otitis media: tobacco use (Z72.0)
- H66 Suppurative and unspecified otitis media: tobacco use (Z72.0)
- Block I10-I1A Hypertensive diseases: tobacco use (Z72.0)
- I20 Angina pectoris: tobacco use (Z72.0)
- I21 Acute myocardial infarction: tobacco use (Z72.0)
- I22 Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction: tobacco use (Z72.0)
- I25 Chronic ischemic heart disease: tobacco use (Z72.0)
- Block I60-I69 Cerebrovascular diseases: tobacco use (Z72.0)
- I70 Atherosclerosis: tobacco use (Z72.0)
- Chapter 10 (J00-J99) Diseases of the respiratory system: tobacco use (Z72.0)
- J37 Chronic laryngitis and laryngotracheitis: tobacco use (Z72.0)
- J40 Bronchitis, not specified as acute or chronic: tobacco use (Z72.0)
- J41 Simple and mucopurulent chronic bronchitis: tobacco use (Z72.0)
- J42 Unspecified chronic bronchitis: tobacco use (Z72.0)
- J45 Asthma: tobacco use (Z72.0)
- J47 Bronchiectasis: tobacco use (Z72.0)
- J81 Pulmonary edema: tobacco use (Z72.0)
- J98 Other respiratory disorders: tobacco use (Z72.0)
- K05 Gingivitis and periodontal diseases: tobacco use (Z72.0)
- K11 Diseases of salivary glands: tobacco use (Z72.0)
- K12 Stomatitis and related lesions: tobacco use (Z72.0)
- K13 Other diseases of lip and oral mucosa: tobacco use (Z72.0)
- K14 Diseases of tongue: tobacco use (Z72.0)
- Z85 Personal history of malignant neoplasm: tobacco use (Z72.0)
- Z77.22 Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic)
- C07 Malignant neoplasm of parotid gland: exposure to environmental tobacco smoke (Z77.22)
- C08 Malignant neoplasm of other and unspecified major salivary glands: exposure to environmental tobacco smoke (Z77.22)
- C09 Malignant neoplasm of tonsil: exposure to environmental tobacco smoke (Z77.22)
- C10 Malignant neoplasm of oropharynx: exposure to environmental tobacco smoke (Z77.22)
- C11 Malignant neoplasm of nasopharynx: exposure to environmental tobacco smoke (Z77.22)
- C12 Malignant neoplasm of pyriform sinus: exposure to environmental tobacco smoke (Z77.22)
- C13 Malignant neoplasm of hypopharynx: exposure to environmental tobacco smoke (Z77.22)
- C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx: exposure to environmental tobacco smoke (Z77.22)
- C32 Malignant neoplasm of larynx: exposure to environmental tobacco smoke (Z77.22)
- C33 Malignant neoplasm of trachea: exposure to environmental tobacco smoke (Z77.22)
- C34 Malignant neoplasm of bronchus and lung: exposure to environmental tobacco smoke (Z77.22)
- C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs: exposure to environmental tobacco smoke (Z77.22)
- D00.0 Carcinoma in situ of lip, oral cavity and pharynx: exposure to environmental tobacco smoke (Z77.22)
- D02 Carcinoma in situ of middle ear and respiratory system: exposure to environmental tobacco smoke (Z77.22)
- G31.84 Mild cognitive impairment of uncertain or unknown etiology: exposure to environmental tobacco smoke (Z77.22)
- H65 Nonsuppurative otitis media: exposure to environmental tobacco smoke (Z77.22)
- H66 Suppurative and unspecified otitis media: exposure to environmental tobacco smoke (Z77.22)
- Block I10-I1A Hypertensive diseases: exposure to environmental tobacco smoke (Z77.22)
- I20 Angina pectoris: exposure to environmental tobacco smoke (Z77.22)
- I21 Acute myocardial infarction: exposure to environmental tobacco smoke (Z77.22)
- I22 Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction: exposure to environmental tobacco smoke (Z77.22)
- I25 Chronic ischemic heart disease: exposure to environmental tobacco smoke (Z77.22)
- Block I60-I69 Cerebrovascular diseases: exposure to environmental tobacco smoke (Z77.22)
- I70 Atherosclerosis: exposure to environmental tobacco smoke (Z77.22)
- Chapter 10 (J00-J99) Diseases of the respiratory system: exposure to environmental tobacco smoke (Z77.22)
- J37 Chronic laryngitis and laryngotracheitis: exposure to environmental tobacco smoke (Z77.22)
- J40 Bronchitis, not specified as acute or chronic: exposure to environmental tobacco smoke (Z77.22)
- J41 Simple and mucopurulent chronic bronchitis: exposure to environmental tobacco smoke (Z77.22)
- J42 Unspecified chronic bronchitis: exposure to environmental tobacco smoke (Z77.22)
- J45 Asthma: exposure to environmental tobacco smoke (Z77.22)
- J47 Bronchiectasis: exposure to environmental tobacco smoke (Z77.22)
- J81 Pulmonary edema: exposure to environmental tobacco smoke (Z77.22)
- J98 Other respiratory disorders: exposure to environmental tobacco smoke (Z77.22)
- K05 Gingivitis and periodontal diseases: exposure to environmental tobacco smoke (Z77.22)
- K11 Diseases of salivary glands: exposure to environmental tobacco smoke (Z77.22)
- K12 Stomatitis and related lesions: exposure to environmental tobacco smoke (Z77.22)
- K13 Other diseases of lip and oral mucosa: exposure to environmental tobacco smoke (Z77.22)
- K14 Diseases of tongue: exposure to environmental tobacco smoke (Z77.22)
- T65.22 Toxic effect of tobacco cigarettes: code for exposure to second hand tobacco smoke (Z57.31, Z77.22)
- Z85 Personal history of malignant neoplasm: exposure to environmental tobacco smoke (Z77.22)
- Z78.0 Asymptomatic menopausal state
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels: postmenopausal status (Z78.0)
- Z79.01 Long term (current) use of anticoagulants
- I27.82 Chronic pulmonary embolism: code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01)
- I82.5 Chronic embolism and thrombosis of deep veins of lower extremity: code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01)
- I82.7 Chronic embolism and thrombosis of veins of upper extremity: code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01)
- I82.8 Embolism and thrombosis of other specified veins: code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01)
- O22.3 Deep phlebothrombosis in pregnancy: code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01)
- O87.1 Deep phlebothrombosis in the puerperium: code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01)
- Z79.4 Long term (current) use of insulin
- E08 Diabetes mellitus due to underlying condition: insulin (Z79.4)
- E09 Drug or chemical induced diabetes mellitus: insulin (Z79.4)
- E11 Type 2 diabetes mellitus: insulin (Z79.4)
- E13 Other specified diabetes mellitus: insulin (Z79.4)
- E89.1 Postprocedural hypoinsulinemia: insulin use (Z79.4)
- O24.1 Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium: long-term (current) use of insulin (Z79.4)
- O24.3 Unspecified pre-existing diabetes mellitus in pregnancy, childbirth and the puerperium: long-term (current) use of insulin (Z79.4)
- O24.8 Other pre-existing diabetes mellitus in pregnancy, childbirth, and the puerperium: long-term (current) use of insulin (Z79.4)
- O24.9 Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium: long-term (current) use of insulin (Z79.4)
- Z90.41 Acquired absence of pancreas: insulin use (Z79.4)
- Z79.52 Long term (current) use of systemic steroids
- D84.821 Immunodeficiency due to drugs: long term (current) drug therapy systemic steroids (Z79.52)
- Z79.84 Long term (current) use of oral hypoglycemic drugs
- E08 Diabetes mellitus due to underlying condition: oral antidiabetic drugs (Z79.84)
- E08 Diabetes mellitus due to underlying condition: oral hypoglycemic drugs (Z79.84)
- E09 Drug or chemical induced diabetes mellitus: oral antidiabetic drugs (Z79.84)
- E09 Drug or chemical induced diabetes mellitus: oral hypoglycemic drugs (Z79.84)
- E11 Type 2 diabetes mellitus: oral antidiabetic drugs (Z79.84)
- E11 Type 2 diabetes mellitus: oral hypoglycemic drugs (Z79.84)
- E13 Other specified diabetes mellitus: oral antidiabetic drugs (Z79.84)
- E13 Other specified diabetes mellitus: oral hypoglycemic drugs (Z79.84)
- Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
- E08 Diabetes mellitus due to underlying condition: injectable non-insulin antidiabetic drugs (Z79.85)
- E09 Drug or chemical induced diabetes mellitus: injectable non-insulin antidiabetic drugs (Z79.85)
- E11 Type 2 diabetes mellitus: injectable non-insulin antidiabetic drugs (Z79.85)
- E13 Other specified diabetes mellitus: injectable non-insulin antidiabetic drugs (Z79.85)
- O24.1 Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium: injectable non-insulin antidiabetic drugs (Z79.85)
- O24.3 Unspecified pre-existing diabetes mellitus in pregnancy, childbirth and the puerperium: injectable non-insulin antidiabetic drugs (Z79.85)
- O24.8 Other pre-existing diabetes mellitus in pregnancy, childbirth, and the puerperium: injectable non-insulin antidiabetic drugs (Z79.85)
- O24.9 Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium: injectable non-insulin antidiabetic drugs (Z79.85)
- Z79.899 Other long term (current) drug therapy
- D84.821 Immunodeficiency due to drugs: other long term (current) drug therapy (Z79.899)
- Z80.3 Family history of malignant neoplasm of breast
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels: family history of breast cancer (Z80.3)
- Z12 Encounter for screening for malignant neoplasms: code to identify any family history of malignant neoplasm (Z80.-)
- Z15 Genetic susceptibility to disease: code, if applicable, for any associated family history of the disease (Z80-Z84)
- Z85.3 Personal history of malignant neoplasm of breast
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels: personal history of breast cancer (Z85.3)
- Z85.46 Personal history of malignant neoplasm of prostate
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels: personal history of prostate cancer (Z85.46)
- Z86.16 Personal history of COVID-19
- M35.81 Multisystem inflammatory syndrome: personal history of COVID-19 (Z86.16)
- Z09 Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm: code to identify any applicable history of disease code (Z86.-, Z87.-)
- Z87.310 Personal history of (healed) osteoporosis fracture
- M81 Osteoporosis without current pathological fracture: personal history of (healed) osteoporosis fracture, if applicable (Z87.310)
- Z87.821 Personal history of retained foreign body fully removed
- Block T51-T65 Toxic effects of substances chiefly nonmedicinal as to source: personal history of foreign body fully removed (Z87.821)
- F64.1 Dual role transvestism: code to identify sex reassignment status (Z87.890-)
- Z87.891 Personal history of nicotine dependence
- C00 Malignant neoplasm of lip: history of tobacco dependence (Z87.891)
- C01 Malignant neoplasm of base of tongue: history of tobacco dependence (Z87.891)
- C02 Malignant neoplasm of other and unspecified parts of tongue: history of tobacco dependence (Z87.891)
- C03 Malignant neoplasm of gum: history of tobacco dependence (Z87.891)
- C04 Malignant neoplasm of floor of mouth: history of tobacco dependence (Z87.891)
- C05 Malignant neoplasm of palate: history of tobacco dependence (Z87.891)
- C06 Malignant neoplasm of other and unspecified parts of mouth: history of tobacco dependence (Z87.891)
- C07 Malignant neoplasm of parotid gland: history of tobacco dependence (Z87.891)
- C08 Malignant neoplasm of other and unspecified major salivary glands: history of tobacco dependence (Z87.891)
- C09 Malignant neoplasm of tonsil: history of tobacco dependence (Z87.891)
- C10 Malignant neoplasm of oropharynx: history of tobacco dependence (Z87.891)
- C11 Malignant neoplasm of nasopharynx: history of tobacco dependence (Z87.891)
- C12 Malignant neoplasm of pyriform sinus: history of tobacco dependence (Z87.891)
- C13 Malignant neoplasm of hypopharynx: history of tobacco dependence (Z87.891)
- C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx: history of tobacco dependence (Z87.891)
- C32 Malignant neoplasm of larynx: history of tobacco dependence (Z87.891)
- C33 Malignant neoplasm of trachea: history of tobacco dependence (Z87.891)
- C34 Malignant neoplasm of bronchus and lung: history of tobacco dependence (Z87.891)
- C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs: history of tobacco dependence (Z87.891)
- D00.0 Carcinoma in situ of lip, oral cavity and pharynx: history of tobacco dependence (Z87.891)
- D02 Carcinoma in situ of middle ear and respiratory system: history of tobacco dependence (Z87.891)
- G31.84 Mild cognitive impairment of uncertain or unknown etiology: history of tobacco dependence (Z87.891)
- H65 Nonsuppurative otitis media: history of tobacco dependence (Z87.891)
- H66 Suppurative and unspecified otitis media: history of tobacco dependence (Z87.891)
- Block I10-I1A Hypertensive diseases: history of tobacco dependence (Z87.891)
- I20 Angina pectoris: history of tobacco dependence (Z87.891)
- I21 Acute myocardial infarction: history of tobacco dependence (Z87.891)
- I22 Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction: history of tobacco dependence (Z87.891)
- I25 Chronic ischemic heart disease: history of tobacco dependence (Z87.891)
- Block I60-I69 Cerebrovascular diseases: history of tobacco dependence (Z87.891)
- I70 Atherosclerosis: history of tobacco dependence (Z87.891)
- Chapter 10 (J00-J99) Diseases of the respiratory system: history of tobacco dependence (Z87.891)
- J37 Chronic laryngitis and laryngotracheitis: history of tobacco dependence (Z87.891)
- J40 Bronchitis, not specified as acute or chronic: history of tobacco dependence (Z87.891)
- J41 Simple and mucopurulent chronic bronchitis: history of tobacco dependence (Z87.891)
- J42 Unspecified chronic bronchitis: history of tobacco dependence (Z87.891)
- J45 Asthma: history of tobacco dependence (Z87.891)
- J47 Bronchiectasis: history of tobacco dependence (Z87.891)
- J81 Pulmonary edema: history of tobacco dependence (Z87.891)
- J98 Other respiratory disorders: history of tobacco dependence (Z87.891)
- K05 Gingivitis and periodontal diseases: history of tobacco dependence (Z87.891)
- K11 Diseases of salivary glands: history of tobacco dependence (Z87.891)
- K12 Stomatitis and related lesions: history of tobacco dependence (Z87.891)
- K13 Other diseases of lip and oral mucosa: history of tobacco dependence (Z87.891)
- K14 Diseases of tongue: history of tobacco dependence (Z87.891)
- Z85 Personal history of malignant neoplasm: history of tobacco dependence (Z87.891)
- Z87.892 Personal history of anaphylaxis
- D89.44 Hereditary alpha tryptasemia: personal history of anaphylaxis (Z87.892)
- Z09 Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm: code to identify any applicable history of disease code (Z86.-, Z87.-)
- Z47.81 Encounter for orthopedic aftercare following surgical amputation: code to identify the limb amputated (Z89.-)
- E89.1 Postprocedural hypoinsulinemia: acquired absence of pancreas (Z90.41-)
- R87.62 Abnormal cytological findings in specimens from vagina: code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)
- Z01.41 Encounter for routine gynecological examination: to identify acquired absence of uterus, if applicable (Z90.71-)
- Z12.72 Encounter for screening for malignant neoplasm of vagina: code to identify acquired absence of uterus (Z90.71-)
- Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm: code to identify any acquired absence of organs (Z90.-)
- K52.2 Allergic and dietetic gastroenteritis and colitis: code to identify type of food allergy (Z91.01-, Z91.02-)
- Z91.02- Food additives allergy status
- K52.2 Allergic and dietetic gastroenteritis and colitis: code to identify type of food allergy (Z91.01-, Z91.02-)
- D89.44 Hereditary alpha tryptasemia: allergy status, other than to drugs and biological substances (Z91.0-)
- Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances: underdosing of medication regimen (Z91.12-, Z91.13-)
- Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances: underdosing of medication regimen (Z91.12-, Z91.13-)
- Z91.83 Wandering in diseases classified elsewhere
- F01.518 Vascular dementia, unspecified severity, with other behavioral disturbance: code, if applicable, to identify wandering in vascular dementia (Z91.83)
- F01.A18 Vascular dementia, mild, with other behavioral disturbance: code, if applicable, to identify wandering in vascular dementia (Z91.83)
- F01.B18 Vascular dementia, moderate, with other behavioral disturbance: code, if applicable, to identify wandering in vascular dementia (Z91.83)
- F01.C18 Vascular dementia, severe, with other behavioral disturbance: code, if applicable, to identify wandering in vascular dementia (Z91.83)
- F02.818 Dementia in other diseases classified elsewhere, unspecified severity, with other behavioral disturbance: code, if applicable, to identify wandering in dementia in conditions classified elsewhere (Z91.83)
- F02.A18 Dementia in other diseases classified elsewhere, mild, with other behavioral disturbance: code, if applicable, to identify wandering in dementia in conditions classified elsewhere (Z91.83)
- F02.B18 Dementia in other diseases classified elsewhere, moderate, with other behavioral disturbance: code, if applicable, to identify wandering in dementia in conditions classified elsewhere (Z91.83)
- F02.C18 Dementia in other diseases classified elsewhere, severe, with other behavioral disturbance: code, if applicable, to identify wandering in dementia in conditions classified elsewhere (Z91.83)
- F03.918 Unspecified dementia, unspecified severity, with other behavioral disturbance: code, if applicable, to identify wandering in unspecified dementia (Z91.83)
- F03.A18 Unspecified dementia, mild, with other behavioral disturbance: code, if applicable, to identify wandering in unspecified dementia (Z91.83)
- F03.B18 Unspecified dementia, moderate, with other behavioral disturbance: code, if applicable, to identify wandering in unspecified dementia (Z91.83)
- F03.C18 Unspecified dementia, severe, with other behavioral disturbance: code, if applicable, to identify wandering in unspecified dementia (Z91.83)
- Z92.82 Status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility
- I21 Acute myocardial infarction: status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility (Z92.82)
- I22 Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction: status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility (Z92.82)
- I63 Cerebral infarction: code, if applicable, to identify status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility (Z92.82)
- Z93.3 Colostomy status
- K90.822 Short bowel syndrome without colon in continuity: code, if applicable, for colostomy status (Z93.3)
- L24.B Irritant contact dermatitis related to stoma or fistula: code to identify any artificial opening status (Z93.-), if applicable, for contact dermatitis related to stoma secretions
- Z94.0 Kidney transplant status
- N18 Chronic kidney disease (CKD): kidney transplant status (Z94.0)
- Z96.1 Presence of intraocular lens
- Z98.4 Cataract extraction status: code to identify intraocular lens implant status (Z96.1)
- M97.8 Periprosthetic fracture around other internal prosthetic joint: code to identify the joint (Z96.6-)
- T84.018 Broken internal joint prosthesis, other site: code to identify the joint (Z96.6-)
- T84.028 Dislocation of other internal joint prosthesis: code to identify the joint (Z96.6-)
- T84.038 Mechanical loosening of other internal prosthetic joint: code to identify the joint (Z96.6-)
- T84.058 Periprosthetic osteolysis of other internal prosthetic joint: code to identify the joint (Z96.6-)
- T84.068 Wear of articular bearing surface of other internal prosthetic joint: code to identify the joint (Z96.6-)
- T84.098 Other mechanical complication of other internal joint prosthesis: code to identify the joint (Z96.6-)
- Z47.1 Aftercare following joint replacement surgery: code to identify the joint (Z96.6-)
- Z97.2 Presence of dental prosthetic device (complete) (partial)
- K06.2 Gingival and edentulous alveolar ridge lesions associated with trauma: code (Chapter 20) to identify external cause or denture status (Z97.2)
- Z98.82 Breast implant status
- C84.7A Anaplastic large cell lymphoma, ALK-negative, breast: breast implant status (Z98.82)
- Z98.86 Personal history of breast implant removal
- C84.7A Anaplastic large cell lymphoma, ALK-negative, breast: personal history of breast implant removal (Z98.86)
- Z99.2 Dependence on renal dialysis
- N18.6 End stage renal disease: code to identify dialysis status (Z99.2)
The first view lists notes printed in this chapter (a note on a category or block applies to every code beneath it). The second lists codes of this chapter named by Use Additional Code Notes anywhere in the Tabular List, including notes in other chapters.
Questions About Use Additional Code Notes
What does a Use Additional Code note mean?
A Use Additional Code note tells you to add a second code, reported after the code that carries the note, to describe the condition completely. In an etiology/manifestation pair it sits at the etiology code and points to the manifestation (Section I.A.13). The FY 2027 Tabular List has 1,491 of them; 1,174 name other codes, with 1,438 references to 389 distinct codes, categories and ranges.
Where does the additional code go?
After the code carrying the note. For etiology/manifestation pairs the Guidelines are explicit: the etiology is sequenced first, followed by the manifestation code.
Related References
Source: FY 2027 ICD-10-CM Tabular List (CMS and NCHS) and the ICD-10-CM Official Guidelines for Coding and Reporting FY 2027, Section I.A. ICD List is not affiliated with CMS or NCHS.